Effect of Light and Cytokinin Modulators on Adventitious Shooting in Melia volkensii Gürke. [PDF]
Bhogar Suresh N +3 more
europepmc +1 more source
Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer. [PDF]
Kampel L +14 more
europepmc +1 more source
Reversible sorafenib-associated coagulopathy identified by viscoelastic testing in a dog with intranasal sarcoma. [PDF]
Kim D, Jo Y, Kim S, Choi M, Kim Y.
europepmc +1 more source
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. [PDF]
Li SH +10 more
europepmc +1 more source
Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis. [PDF]
Gkoufa A +6 more
europepmc +1 more source
Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach. [PDF]
Nakhleh A +5 more
europepmc +1 more source
A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib. [PDF]
Lee SW +6 more
europepmc +1 more source
Lenvatinib-Induced Acalculous Cholecystitis-An Often-Unrecognized Toxicity: A Case Series and Literature Review. [PDF]
Cortas C, Symeonidou C, Charalambous H.
europepmc +1 more source
Mild and efficient synthesis of carbamates using dioxazolones as bench-stable isocyanate surrogates: application in AChE-inhibiting agent development. [PDF]
Wu Y +7 more
europepmc +1 more source
Long Term Disease Control of Brain Metastases From Chemotherapy-Resistant Endometrial Cancer With Lenvatinib and Pembrolizumab: A Case Report. [PDF]
Fujioka A +5 more
europepmc +1 more source

